The Secondary Suite Incentive Program supports safe housing for all. The incentive program will provide qualifying homeowners with up to $10,000 to build and register a secondary suite. The incentive ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

While pregnant, Susana Demore was diagnosed with triple-negative breast cancer. After beating it, she has embraced significant lifestyle changes.

The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Mercer Island-based Rivkin Center for Ovarian Cancer Research will be embarking on a new journey while continuing its crucial mission come April 1. On that day, the vital center that has been in ...

While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal ...

Patients with relapsed ovarian cancer who had germline or somatic BRCA mutations saw greater OS with olaparib, according to ...

To further muddy the waters, card reviews and advertising generally label the insurance as primary or secondary. Before applying for a card, it’s worth knowing the differences between these ...

A diagnosis of metastatic breast cancer can be overwhelming, and one of the many challenges it brings can be social isolation. It's OK to be alone sometimes, and it can even be restorative. However, ...